The transition from relapsing-remitting MS to irreversible disability: clinical evaluation

被引:0
|
作者
M. Trojano
D. Paolicelli
A. Bellacosa
S. Cataldo
机构
[1] University of Bari,Department of Neurological and Psychiatric Sciences
来源
Neurological Sciences | 2003年 / 24卷
关键词
Multiple sclerosis; Disease duration; Prognosis; Age; Disability progression;
D O I
暂无
中图分类号
学科分类号
摘要
The development of a progressive course is by far the most deleterious event in the case of a multiple sclerosis (MS) patient. It occurs in about 90% of relapsing remitting patients by 20–25 years from onset. The clinical transition to secondary progressive MS is phenotypically distinctive and both patients and physicians acknowledge that a fundamental shift in the degree of responsiveness to anti-inflammatory therapies has occurred. This review discusses the clinical studies that provided important findings relating to our understanding on different mechanisms that may contribute to irreversible disability in MS.
引用
收藏
页码:s268 / s270
相关论文
共 50 条
  • [31] NATALIZUMAB FOR RELAPSING-REMITTING MS IN THE UK TOP COHORT
    Nicholas, Richard
    Hanna, Jerome
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [32] Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
    Ferreira, Vanessa F. Moreira
    Meredith, David
    Stankiewicz, James M.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (05):
  • [33] PASAT in detecting cognitive impairment in relapsing-remitting MS
    Rosti, Eija
    Hamalainen, Paivi
    Koivisto, Keijo
    Hokkanen, Laura
    APPLIED NEUROPSYCHOLOGY, 2007, 14 (02): : 101 - 112
  • [34] Memory and executive skills are impaired in relapsing-remitting MS
    Panou, Theodora
    Simos, Panagiotis
    Fassaraki, Chrisoula
    Plaitakis, Andreas
    ANNALS OF NEUROLOGY, 2007, 62 : S57 - S57
  • [35] Verbal Working Memory Function in Relapsing-Remitting MS
    Panou, Theodora
    Simos, Panagiotis
    Mastorodemos, Vasileios
    Plaitakis, Andreas
    ANNALS OF NEUROLOGY, 2009, 66 : S42 - S42
  • [36] Pilot study of a ketogenic diet in relapsing-remitting MS
    Brenton, J. Nicholas
    Banwell, Brenda
    Bergqvist, A. G. Christina
    Lehner-Gulotta, Diana
    Gampper, Lauren
    Leytham, Emily
    Coleman, Rachael
    Goldman, Myla D.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (04):
  • [37] Primary progressive MS/relapsing-remitting MS: one or two diseases?
    Hawkins, SH
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S109 - S110
  • [38] Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
    Migliore, S.
    Ghazaryan, A.
    Simonelli, I.
    Pasqualetti, P.
    Squitieri, F.
    Curcio, G.
    Landi, D.
    Palmieri, M. G.
    Moffa, F.
    Filippi, M. M.
    Vernieri, F.
    BEHAVIOURAL NEUROLOGY, 2017, 2017
  • [39] MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis
    Giugni, E
    Pozzilli, C
    Bastianello, S
    Gasperini, C
    Paolillo, A
    Koudriavtseva, T
    Frontoni, M
    Farina, D
    Bozzao, L
    MULTIPLE SCLEROSIS, 1997, 3 (04): : 221 - 225
  • [40] Clinical predictors of disability in treatment-naive relapsing-remitting multiple sclerosis patients
    Ivaniuk, A.
    Solodovnikova, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 921 - 921